Erwin Hurlbut v. GW Pharmaceuticals Plc et al: Complaint

Complaint in Erwin Hurlbut v. GW Pharmaceuticals Plc, described as a British “biopharmaceutical company focused on discovering, developing, and commercializing novel therapeutics from its proprietary cannabinoid product platform in a broad range of disease areas” whose shares are listed on NASDAQ; Geoffrey Guy, Justin Gover, Cabot Brown, David Gryska, Catherine Mackey, James Noble, Alicia Secor, and William Waldegrave at the U. S. District Court for the Eastern District of Pennsylvania.